摘要
目的:探讨治疗肺结核患者的耐药情况,为今后治疗耐药肺结核病提供科学依据。方法:随机抽取2003年2月-2012年6月本院收治的300例肺结核患者的临床资料,对其痰标本进行10种抗结核药物敏感性试验分析。结果:300例患者的初始耐药率达39.00%,13.67%为单耐药率,13.00%多耐药率,6.33%为耐多药率,广泛耐药率为1.67%,合并艾滋病病毒(HIV)感染耐药率4.33%;单耐药率和多耐药率较高,应该引起广泛关注。结论:肺结核患者的单耐药率和多耐药率相对较高,因此要想有效控制耐药肺结核传染源,必须加强肺结核患者的治疗管理。
Objective：To explore drug resistance of pulmonary tuberculosis patients,to provide scientific basis for the treatment of drug-resistant tuberculosis. Method：The clinical data of 300 cases of pulmonary tuberculosis in our hospital from February 2003 to June 2012 were randomly selected, 10 antituberculosis drug sensitivity test of sputum I coated specimens were analyzed.Result：The study of 300 patients with initial drug resistance rate was 39%,13.67%for single drug resistance rate,more than 13.00%resistance rate,6.33%for the multi drug resistance rate,extensive drug resistance rate was 1.67%,with the AIDS virus（HIV）infection resistance rate 4.33%;single drug resistance rate and multiple drug resistance rate was higher,should arouse wide attention.Conclusion：Single drug resistance rate of patients with pulmonary tuberculosis and multidrug-resistant rate is relatively high,so in order to effectively control the drug-resistant TB infection source,we must strengthen the management of patients with pulmonary tuberculosis.
出处
《中国医学创新》
CAS
2013年第32期135-136,共2页
Medical Innovation of China
关键词
初治痰阳肺结核
耐药性
药敏分析
New smear-positive pulmonary tuberculosis
Drug resistance
Drug susceptibility analysis
